Target intelligence / Profile preview

Ribosomal protein L32 pseudogene 28 (RPL32P28)

Target
RPL32P28
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein L32 pseudogene 28 is a member of the ribosomal protein L32 pseudogene family. Pseudogenes are genomic DNA fragments similar to normal genes but are non-functional; they generally arise from duplication or retrotransposition events. RPL32P28 is not known to be expressed as a protein, nor does it play a direct biological or pharmacological role. It is not considered a therapeutic target, does not encode a receptor, enzyme, transporter, or any functional protein, and does not have known relevance in disease biology or therapeutic interventions[7][8]. The parental gene, RPL32, encodes a protein that is part of the cytoplasmic ribosome 60S subunit and is involved in protein synthesis, but pseudogenes like RPL32P28 do not perform these functions[3][6]. The RPL32 family contains multiple pseudogenes throughout the genome, typical for ribosomal protein families[7][8]. No alternative names or functional protein products are reported for this pseudogene. RPL32P28 is not a functional biological target and should not be considered in analyses focusing on druggability, biomarker utility, or therapeutic intervention. It exists as a DNA sequence artifact related to the RPL32 gene family, with no evidence for functional activity or clinical relevance[7][8].

Beyond the preview

Go deeper on Ribosomal protein L32 pseudogene 28 (RPL32P28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L32 pseudogene 28 (RPL32P28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call